TCL Archive In Brief: Kripke, Fidler To Leave FCRF for M.D. Anderson; George Todaro Takes Job With New Seattle Firm March 4, 1983
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
